Myriad Genetics | MYGN - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Myriad Genetics

Myriad Genetics reported $122M in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Accelerate Diagnostics AXDX:US USD 1.01M 170K
Agilent A:US USD 924M 44M
Becton, Dickinson and Co. BDX:US USD 2.24B 102M
Bruker BRKR:US USD 359.7M 5.9M
Danaher DHR:US USD 4.37B 569M
Exact Sciences EXAS:US USD 445.58M 39.74M
Hologic HOLX:US USD 585.8M 32.1M
Illumina ILMN:US USD 655M 17M
J&J JNJ:US USD 16.35B 356M
Myriad Genetics MYGN:US USD 122M 1.9M
NanoString Technologies NSTG:US USD 12.93M 366K
OraSure Technologies OSUR:US USD 65.85M 16.26M
Pacific Biosciences Of California PACB:US USD 9.76M 916K
Quest Diagnostics DGX:US USD 781M 4M
Quidel QDEL:US USD 448.6M 400K
Repligen RGEN:US USD 100.82M 4.75M
Thermo Fisher Scientific TMO:US USD 4.27B 462M
Waters WAT:US USD 400.29M 110.03M